The latest clinical report from Prime, The evolution of GLP-1s, delves into some of the latest insights, empowering health plans, pharmacies and members with recent research, data, trends and forecasting for these medications, which are approved to treat type 2 diabetes, obesity and cardiovascular conditions
Dexcom Flex reflects the companys commitment to placing people at the centre of the product design process and creates a personalised diabetes guidance experience, rather than offering a one-size-fits-all approach
The Endocrine Society publishes clinical practice guidelines on obesity management that include sections on incretin-based therapies
The study was led by a team of scientists in the United States and Europe, including faculty, postdoctoral and graduate student researchers from the UF colleges of Pharmacy and Medicine
Be sure to ask your doctor about what options are safe for you